Lista de obras - Arik Bernard Schulze - Dominio Público Uruguay

90 Y-ibritumomab-tiuxetan as a therapeutic alternative for follicular lymphoma (FL): A single-center experience

artículo científico publicado en 2018

Alpha-1 Antitrypsin Deficiency and Pulmonary Morbidity in Patients with Primary Immunodeficiency Disease: A Single-Center Experience

scientific article published on 27 May 2020

Blood clot removal by cryoextraction in critically ill patients with pulmonary hemorrhage

scientific article published on 01 October 2019

Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLC.

artículo científico publicado en 2015

Detection of Histoplasma DNA from Tissue Blocks by a Specific and a Broad-Range Real-Time PCR: Tools to Elucidate the Epidemiology of Histoplasmosis

scientific article published on 27 November 2020

Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer.

artículo científico publicado en 2019

Nivolumab in a patient with refractory Hodgkin's lymphoma after allogeneic stem cell transplantation

artículo científico publicado en 2015

Noncaseating granulomatous diseases in germ cell cancer patients-A single-center experience

scientific article published on 30 April 2019

PD-1 targeted Immunotherapy as first-line therapy for advanced non-small-cell lung cancer patients

artículo científico publicado en 2017

Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC

scientific article published on 24 November 2019

Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia.

artículo científico publicado en 2016

Progressive histoplasmosis with hemophagocytic lymphohistiocytosis and epithelioid cell granulomatosis: A case report and review of the literature.

artículo científico publicado en 2017

Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer.

artículo científico publicado en 2017

Rhesus CE expression on patient red blood cells is an independent prognostic factor for adenocarcinoma of the lung.

artículo científico publicado en 2017

Soluble Triggering Receptor Expressed on Myeloid Cells 1 in lung cancer

scientific article published on 17 July 2018

Thoracic Malignancies and Pulmonary Nodules in Patients under Evaluation for Transcatheter Aortic Valve Implantation (TAVI): Incidence, Follow Up and Possible Impact on Treatment Decision.

artículo científico publicado en 2016

Lista de obras de Arik Bernard Schulze

90 Y-ibritumomab-tiuxetan as a therapeutic alternative for follicular lymphoma (FL): A single-center experience

Alpha-1 Antitrypsin Deficiency and Pulmonary Morbidity in Patients with Primary Immunodeficiency Disease: A Single-Center Experience

Blood clot removal by cryoextraction in critically ill patients with pulmonary hemorrhage

Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLC.

Detection of Histoplasma DNA from Tissue Blocks by a Specific and a Broad-Range Real-Time PCR: Tools to Elucidate the Epidemiology of Histoplasmosis

Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer.

Nivolumab in a patient with refractory Hodgkin's lymphoma after allogeneic stem cell transplantation

Noncaseating granulomatous diseases in germ cell cancer patients-A single-center experience

PD-1 targeted Immunotherapy as first-line therapy for advanced non-small-cell lung cancer patients

Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC

Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia.

Progressive histoplasmosis with hemophagocytic lymphohistiocytosis and epithelioid cell granulomatosis: A case report and review of the literature.

Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer.

Rhesus CE expression on patient red blood cells is an independent prognostic factor for adenocarcinoma of the lung.

Soluble Triggering Receptor Expressed on Myeloid Cells 1 in lung cancer

Thoracic Malignancies and Pulmonary Nodules in Patients under Evaluation for Transcatheter Aortic Valve Implantation (TAVI): Incidence, Follow Up and Possible Impact on Treatment Decision.